ZOLADEX 3.6 MG (GOSERELIN (GOSERELIN ACETATE) IMPLANT) 3.6 MG

Zoladex 3.6 mg is a subcutaneous implant containing goserelin acetate, used for hormone-related conditions. This long-acting implant is designed for convenient, sustained release.

Strength

3.6 MG

Pack Size

ONE DEPOT

Manufacturer / TM Owner

TERSERA THERAPEUTICS LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zoladex 3.6 mg is primarily used for conditions that require hormone suppression, such as certain types of cancer or hormonal imbalances. Goserelin acetate works by reducing the production of specific hormones, which can help manage symptoms associated with these conditions. Patients often wonder, 'What is Zoladex 3.6 mg used for?'—it is typically prescribed for hormone-sensitive conditions where long-term treatment is beneficial.

Side Effects

Common effects of Zoladex 3.6 mg may include temporary changes in hormone levels, which can lead to symptoms like hot flashes or mood changes. Some users may experience localized reactions at the injection site. These effects vary and are not experienced by everyone.

Precautions & Warnings

Zoladex 3.6 mg should be handled with care, following the instructions provided by a healthcare professional. It is important to store and administer the implant correctly to ensure its effectiveness and safety. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Goserelin acetate may interact with other medications, particularly those that affect hormone levels or are metabolized by the liver. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effects of Zoladex 3.6 mg.

References

Frequently Asked Questions

Zoladex 3.6 mg is used for hormone-related conditions that require long-term hormone suppression, such as certain types of cancer or hormonal imbalances.

Zoladex 3.6 mg is administered as a subcutaneous implant, typically inserted by a healthcare professional.

Common side effects may include hot flashes, mood changes, and localized reactions at the injection site.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Zoladex 3.6 mg is designed for long-term use, with effects lasting several months.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.